The Effects of Anesthesia Depth Monitoring on Postoperative Recovery and Cognitive Functions in the Geriatric Patient Population

February 26, 2025 updated by: Aslıhan Güleç

Geriatrik Hasta Grubunda Anestezi Derinliği Monitörizasyonlarının Postoperatif Derlenme Ve Bilişsel Fonksiyonlara Etkileri

This study will be conducted on patients aged 65 and older scheduled for surgery due to lumbar or cervical disc herniation. General anesthesia is routinely used for these types of surgeries in the hospital. In patients receiving general anesthesia, anesthesia depth monitoring is performed.

As part of the study, a preoperative anesthesia evaluation will be conducted, which will include age, weight, height, comorbidities, regularly used medications, previous surgical or anesthesia experiences, nutritional habits, mental status, and daily activity levels.

On the day of surgery, upon arrival in the operating room, the following will be measured and recorded:

  • Blood pressure using a non-invasive blood pressure monitor
  • Heart rate and rhythm via electrocardiogram (ECG)
  • Blood oxygen level with a pulse oximeter
  • Anesthesia depth using a forehead-applied sensor

All monitoring procedures are non-invasive and painless. Following the placement of these monitoring devices and initial measurements, anesthesia induction and surgery will commence. Throughout surgery, blood pressure, heart rate, and brain activity will be continuously recorded. After the surgical procedure, anesthesia emergence and mental status will be assessed. Preoperative evaluation data and intraoperative recordings will be used solely for research purposes, with patient identity information remaining confidential.

Study Overview

Detailed Description

Perioperative cognitive decline and delirium occur more frequently in the geriatric population undergoing surgery. International guidelines recommend monitoring anesthesia depth to reduce the risk of postoperative cognitive dysfunction. Anesthesia depth is commonly measured using non-invasive electroencephalography (EEG)-based methods, such as the Bispectral Index (BIS).

Previous studies have predominantly utilized processed EEG monitors that generate numerical values for tracking anesthesia depth. However, in this study, anesthesia depth will be monitored using both the standard numerical BIS index and the Density Spectral Array (DSA) mode, an advanced feature of the BIS device. To date, no studies have simultaneously examined BIS and DSA modes in relation to cognitive function and the recovery process.

The use of advanced monitoring techniques may serve as a valuable resource for future research, particularly in optimizing anesthetic management for geriatric patients with reduced cognitive reserve. This study aims to evaluate the effects of different intraoperative anesthesia depth monitoring approaches, including hemodynamic monitoring, numerical BIS values, and DSA functions. The primary objective is to determine the optimal anesthesia monitoring strategy that minimizes intraoperative hypotension, burst suppression, and postoperative delirium.

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ankara, Turkey, 06560
        • Recruiting
        • Gazi University School of Medicine
        • Contact:
        • Contact:
        • Contact:
          • Aslihan Gulec Kilic, MD
        • Contact:
          • Gozde Inan, Associate Professor
        • Contact:
          • Zerrin Ozkose Satirlar, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 65 years and older
  • Elective spinal surgeries
  • ASA status I-III

Exclusion Criteria:

  • Emergent surgeries
  • ASA status IV-V
  • Prediagnosed delirium and or dementia
  • Inability to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Hemodynamic-Guided Group
Anesthesia depth monitoring will be managed according to hemodynamic parameters, primarily avoiding hypotension.
Anesthesia depth monitoring based on hemodynamic values without additional processed EEG guidance.
Active Comparator: BIS-Guided Group
Anaesthesia depth monitoring according to numeric BIS index values
Anaesthesia depth monitoring according to numeric BIS index values.
Active Comparator: DSA-Guided Group
Anesthesia depth monitoring using the Density Spectral Array (DSA) function of the BIS monitor.
Anaesthesia depth monitoring according to density spectral array functions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ratio of Burst Suppression
Time Frame: Intraoperative (continuously recorded from anesthesia induction to emergence)
The burst suppression ratio (BSR) will be calculated as the percentage of total anesthesia time spent in burst suppression, as measured by processed electroencephalography (EEG). A higher BSR has been associated with worse postoperative cognitive outcomes.
Intraoperative (continuously recorded from anesthesia induction to emergence)
Time of Burst Suppression
Time Frame: Intraoperative (continuously recorded from anesthesia induction to emergence)
Anesthesia time spent in burst suppression (BS), as measured by processed electroencephalography (EEG). A higher BS time has been associated with worse postoperative cognitive outcomes.
Intraoperative (continuously recorded from anesthesia induction to emergence)
Intraoperative Hypotension Incidence
Time Frame: Intraoperative (assessed continuously throughout surgery)
Intraoperative hypotension will be measured in 5-minute intervals. Hypotension is a mean arterial pressure (MAP) below 60 mmHg. The episodes of hypotension at any point during surgery will be recorded.
Intraoperative (assessed continuously throughout surgery)
Alpha Band Preservation or Loss
Time Frame: Intraoperative (measured continuously from anesthesia induction to emergence)
Alpha band activity (8-12 Hz) in the frontal lobe will be evaluated to determine whether it is preserved or lost during general anesthesia. Alpha band preservation is associated with optimal anesthesia depth and cognitive function preservation, while loss of alpha band activity is linked to increased postoperative cognitive impairment.
Intraoperative (measured continuously from anesthesia induction to emergence)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Postoperative Delirium Assessed via CAM Scale
Time Frame: Postoperative (assessed at 6, 24, and 48 hours after surgery)
Postoperative delirium will be assessed using the Confusion Assessment Method (CAM) tool. The number of participants meeting the criteria for delirium within the first 48 hours postoperatively will be recorded.
Postoperative (assessed at 6, 24, and 48 hours after surgery)
Total Intraoperative Propofol Consumption
Time Frame: Intraoperative
The total dose of propofol administered intraoperatively will be recorded. Data will be reported as mg/kg.
Intraoperative
Total Intraoperative Sevoflurane Consumption
Time Frame: Intraoperative
The total dose of Sevoflurane administered intraoperatively will be recorded. Data will be reported as ml.
Intraoperative
Total Intraoperative Remifentanil Consumption
Time Frame: Intraoperative
The total dose of Remifentanil administered intraoperatively will be recorded. Data will be reported as mcg/kg.
Intraoperative
Total Intraoperative Vasopressor Consumption
Time Frame: Intraoperative
The total dose of vasopressors (noradrenaline, adrenaline, dopamine) administered intraoperatively will be recorded. Data will be reported as mcg/kg.
Intraoperative

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty Score Assessed via Clinical Frailty Scale (CFS)
Time Frame: Preoperative (assessed on the day of surgery)
Frailty will be assessed preoperatively using the Clinical Frailty Scale (CFS), which ranges from 1 (very fit) to 9 (terminally ill). Higher scores indicate worse frailty status. The proportion of participants classified as frail (CFS ≥ 5) will be reported.
Preoperative (assessed on the day of surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Zerrin Ozkose Satirlar, Professor, Gazi University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2025

Primary Completion (Estimated)

March 15, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

February 9, 2025

First Submitted That Met QC Criteria

February 19, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 26, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in the publication

IPD Sharing Time Frame

Beginning 3 months and ending one year after the publication

IPD Sharing Access Criteria

Access to study protocol upon request, contact with one of the sub-investigators.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium (POD)

Clinical Trials on Control Group: Standard Hemodynamic Monitoring

Subscribe